June 2012 FDA Recall Cardiogen-82 by Bracco Diagnostics Inc
D-1684-2012 - GMP deviation; Sr-82 levels exceeded alert limit specification

This Class II drug recall was voluntarily initiated by Bracco Diagnostics Inc on June 1, 2012 for the product Cardiogen-82. The FDA reported the reason for recall as gmp deviation; sr-82 levels exceeded alert limit specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1684-2012

Reason for Recall
GMP deviation; Sr-82 levels exceeded alert limit specification
Initiated
06-01-2012
Reported
10-03-2012
Quantity
54 generators

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Bracco Diagnostics Inc
Nationwide and United Kingdom
CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile nonpyrogenic Rubidium Chloride Rb 82, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Medi-Physics, Inc. South Plainfield, NJ 07080, NDC 0270-0091-01

Batch or Lot Expiration Information

Lot# Lot numbers 09101-121251 and 09101-121391

Affected Packages Involved in this Recall